105823-04-9 Usage
Uses
Used in Scientific Research:
1',2'-dimethylheptyl-1-deoxy-delta(8)-tetrahydrocannabinol is used as a research compound for studying the effects of cannabinoids on the body. It serves as a valuable tool in understanding the mechanisms of action and potential therapeutic benefits of cannabinoids, given its high potency and longer-lasting effects compared to natural THC.
Used in Pharmaceutical Development:
In the pharmaceutical industry, DMH-D8-THC is used as a starting point for the development of new medications. Its high potency and unique properties make it a promising candidate for the creation of drugs that could address a variety of medical conditions, pending further research into its safety and efficacy.
Used in Medical Applications:
Although still under investigation, 1',2'-dimethylheptyl-1-deoxy-delta(8)-tetrahydrocannabinol is considered for potential use in medical applications due to its potent agonist activity at cannabinoid receptors. It may offer therapeutic benefits for conditions that could benefit from modulation of the endocannabinoid system, such as chronic pain, inflammation, and certain neurological disorders, once its effects and risks are thoroughly understood.
Check Digit Verification of cas no
The CAS Registry Mumber 105823-04-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,8,2 and 3 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 105823-04:
(8*1)+(7*0)+(6*5)+(5*8)+(4*2)+(3*3)+(2*0)+(1*4)=99
99 % 10 = 9
So 105823-04-9 is a valid CAS Registry Number.
105823-04-9Relevant articles and documents
Novel cannabinol probes for CB1 and CB2 cannabinoid receptors
Mahadevan,Siegel,Martin,Abood,Beletskaya,Razdan
, p. 3778 - 3785 (2000)
The observation that the phenolic hydroxyl of THCs was important for binding to the CB1 receptor but not as critical for binding to the CB2 receptor prompted us to extend this finding to the cannabinol (CBN) series. To study the SAR of CBN analogues, CBN
Structure activity relationships of tetrahydrocannabinol analogues on human cannabinoid receptors
Gareau, Yves,Dufresne, Claude,Gallant, Michel,Rochette, Chantal,Sawyer, Nicole,Slipetz, Deborah M.,Tremblay, Nathalie,Weech, Philip K.,Metters, Kathleen M.,Labelle, Marc
, p. 189 - 194 (1996)
A series of Δ8-tetrahydrocannabinol (THC) and biphenylic derivatives were prepared and their binding affinity for both human cannabinoid receptors hCB1 and hCB2 evaluated.
CANNABINOIDS AND USES THEREOF
-
Page/Page column 92-93, (2019/12/25)
The invention relates to cannabinoid compounds, pharmaceutical compositions including one or more cannabinoid compounds, and the use of pharmaceutical compositions including one or more cannabinoid compounds for the treatment of a disease or condition (e.
